My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Short-term hyperglycemic dysregulation in patients with type 1 diabetes does not change myocardial triglyceride content or myocardial function.

    Hammer S, Jonker JT, Lamb HJ, van der Meer RW, Zondag W, Sepers JM, de Roos A, Smit JW, Romijn JA.

    Diabetes Care. 2008 Aug;31(8):1613-4. Epub 2008 May 5.PMID: 18458137 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus.

    Hammer S, van der Meer RW, Lamb HJ, de Boer HH, Bax JJ, de Roos A, Romijn JA, Smit JW.

    Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E714-8. Epub 2008 Jul 15.PMID: 18628354 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men.

    Hammer S, van der Meer RW, Lamb HJ, Schär M, de Roos A, Smit JW, Romijn JA.

    J Clin Endocrinol Metab. 2008 Feb;93(2):497-503. Epub 2007 Nov 20.PMID: 18029455 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects.

    van der Meer RW, Hammer S, Smit JW, Frölich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ.

    Diabetes. 2007 Dec;56(12):2849-53. Epub 2007 Aug 23.PMID: 17717279 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men.

    van der Meer RW, Hammer S, Lamb HJ, Frölich M, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Smit JW.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2702-8. Epub 2008 Apr 22.PMID: 18430773 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function.

    Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, Meinders EA, Romijn JA, de Roos A, Smit JW.

    J Am Coll Cardiol. 2008 Sep 16;52(12):1006-12.PMID: 18786482 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic MRI of myocardial and hepatic triglyceride content in response to nutritional interventions.

    Lamb HJ, Smit JW, van der Meer RW, Hammer S, Doornbos J, de Roos A, Romijn JA.

    Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):573-9. Review.PMID: 18685452 [PubMed - indexed for MEDLINE]Related articles

    8.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

    van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M.

    Circulation. 2009 Apr 21;119(15):2069-77. Epub 2009 Apr 6.PMID: 19349323 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.

    Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H.

    Diabetes. 2002 Jul;51(7):2179-89.PMID: 12086948 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes.

    Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS.

    J Investig Med. 2007 Jul;55(5):230-6.PMID: 17850734 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of acute hyperglycemia on plasma triglyceride concentration and triglyceride secretion rate in non-fasted rats.

    Hirano T, Mamo JC, Furukawa S, Nagano S, Takahashi T.

    Diabetes Res Clin Pract. 1990 Jul;9(3):231-8.PMID: 2226122 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

    Jeppesen J, Zhou MY, Chen YD, Reaven GM.

    Diabetes Care. 1994 Oct;17(10):1093-9.PMID: 7821127 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of prolonged hyperglycemia on growth hormone levels and insulin sensitivity in insulin-dependent diabetes mellitus.

    Fowelin J, Attvall S, von Schenck H, Bengtsson BA, Smith U, Lager I.

    Metabolism. 1993 Mar;42(3):387-94.PMID: 8487660 [PubMed - indexed for MEDLINE]Related articles

    16.

    Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.

    Monti LD, Lucignani G, Landoni C, Moresco RM, Piatti P, Stefani I, Pozza G, Fazio F.

    Diabetes. 1995 May;44(5):537-42.PMID: 7729612 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats]

    Ran JM, Lao GC, Xu G, Xie B, Zhang Y, Liu W, Feng Q, Guo J.

    Zhonghua Yi Xue Za Zhi. 2008 Jun 10;88(22):1557-61. Chinese. PMID: 18956640 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

    Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA.

    Diabetes Care. 1996 Jun;19(6):580-6.PMID: 8725855 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.

    Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G.

    Diabetes Care. 1996 Nov;19(11):1207-13.PMID: 8908381 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients.

    Vuorinen-Markkola H, Koivisto VA, Yki-Jarvinen H.

    Diabetes. 1992 May;41(5):571-80.PMID: 1568526 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity